147 related articles for article (PubMed ID: 1623897)
1. The influence of posture on the response to loop diuretics in patients with chronic cardiac failure is reduced by angiotensin converting enzyme inhibition.
Flapan AD; Davies E; Waugh C; Williams BC; Shaw TR; Edwards CR
Eur J Clin Pharmacol; 1992; 42(6):581-5. PubMed ID: 1623897
[TBL] [Abstract][Full Text] [Related]
2. Posture determines the nature of the interaction between angiotensin converting enzyme inhibitors and loop diuretics in patients with chronic cardiac failure.
Flapan AD; Davies E; Waugh C; Williams BC; Shaw TR; Edwards CR
Int J Cardiol; 1991 Dec; 33(3):377-83. PubMed ID: 1761331
[TBL] [Abstract][Full Text] [Related]
3. Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure.
Flapan AD; Davies E; Waugh C; Williams BC; Shaw TR; Edwards CR
Eur Heart J; 1991 Aug; 12(8):924-7. PubMed ID: 1915430
[TBL] [Abstract][Full Text] [Related]
4. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
5. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
Wambach G; Schittenhelm U; Bönner G; Kaufmann W
Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
[TBL] [Abstract][Full Text] [Related]
7. Effect of posture on sodium excretion and diuretic efficacy in nephrotic patients.
Minutolo R; Andreucci M; Balletta MM; Russo D
Am J Kidney Dis; 2000 Oct; 36(4):719-27. PubMed ID: 11007673
[TBL] [Abstract][Full Text] [Related]
8. Activity with ambulation attenuates diuretic responsiveness in chronic heart failure.
Galiwango PJ; McReynolds A; Ivanov J; Chan CT; Floras JS
J Card Fail; 2011 Oct; 17(10):797-803. PubMed ID: 21962416
[TBL] [Abstract][Full Text] [Related]
9. The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
Reed S; Greene P; Ryan T; Cerimele B; Schwertschlag U; Weinberger M; Voelker J
Br J Clin Pharmacol; 1995 Jan; 39(1):51-7. PubMed ID: 7756099
[TBL] [Abstract][Full Text] [Related]
10. [Atrial natriuretic factor in patients with cardiac decompensation before and after chronic therapy with an angiotensin-converting enzyme inhibitor].
Pomini G; Rugna A; Lupia M; Opocher G; Gribaldo R
G Ital Cardiol; 1992 Jul; 22(7):807-12. PubMed ID: 1473654
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure response to angiotensin converting enzyme inhibitor in essential hypertension: its relation to the renin status and natriuresis during acute sodium loading.
Hou CH; Chen YM; Wu KD; Hsieh BS
J Formos Med Assoc; 1993 Nov; 92(11):942-7. PubMed ID: 7910063
[TBL] [Abstract][Full Text] [Related]
12. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for renin profiling in selecting chronic heart failure patients for ACE inhibitor treatment?
Lim PO; MacFadyen RJ; Struthers AD
Heart; 2000 Mar; 83(3):257-61. PubMed ID: 10677399
[TBL] [Abstract][Full Text] [Related]
14. Relationship of the renin-angiotensin system and systemic arterial pressure to sodium excretion during atrial natriuretic peptide infusion in men.
Grandis DJ; Uretsky BF; Verbalis JG; Chong TK; Puschett JB
Am J Hypertens; 1992 Nov; 5(11):793-9. PubMed ID: 1457079
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the short-term effects of candoxatril, an orally active neutral endopeptidase inhibitor, and frusemide in the treatment of patients with chronic heart failure.
Northridge DB; Newby DE; Rooney E; Norrie J; Dargie HJ
Am Heart J; 1999 Dec; 138(6 Pt 1):1149-57. PubMed ID: 10577447
[TBL] [Abstract][Full Text] [Related]
16. The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.
Cleland JG; Gillen G; Dargie HJ
Eur Heart J; 1988 Feb; 9(2):132-41. PubMed ID: 2832173
[TBL] [Abstract][Full Text] [Related]
17. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia.
Adigun AQ; Ajayi AA
Eur J Heart Fail; 2001 Jun; 3(3):359-63. PubMed ID: 11378008
[TBL] [Abstract][Full Text] [Related]
18. The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs.
Lantis AC; Ames MK; Werre S; Atkins CE
J Vet Pharmacol Ther; 2015 Oct; 38(5):513-7. PubMed ID: 25771846
[TBL] [Abstract][Full Text] [Related]
19. Enalapril attenuates natriuresis of atrial natriuretic factor in humans.
Gaillard CA; Koomans HA; Mees EJ
Hypertension; 1988 Feb; 11(2):160-5. PubMed ID: 2830188
[TBL] [Abstract][Full Text] [Related]
20. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
Atlas SA; Case DB; Yu ZY; Laragh JH
Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
